Tenet Healthcare Corporation (NYSE:THC) Price Target Raised Amid Strong Analyst Sentiment

Font: Financial Modeling Prep  • Jul 13, 2026

• Tenet Healthcare Corporation (NYSE:THC) receives an increased price target from Wells Fargo (NYSE:WFC), signaling a positive investor outlook.
• The company maintains a strong "Buy" consensus from Wall Street, reflecting broad analyst confidence in its future performance.
• Despite potential risks from rising operating expenses, Tenet Healthcare demonstrates robust year-to-date growth, outperforming the broader Medical sector.

Tenet Healthcare Corporation is a Dallas-based company that operates a large network of hospitals and outpatient centers. With a market capitalization of approximately $17.50 billion, it is a major entity within the healthcare services industry. The company's performance is often watched closely by investors tracking the broader medical sector.

An analyst from Wells Fargo, Stephen Baxter, has raised the price target for Tenet Healthcare to $231.00 from a previous target of $213.00. This new forecast suggests a potential upside of about 13.10% from the stock's price of $204.25 at the time of the announcement, indicating a positive outlook on the company's future value.

This optimistic view is consistent with broader sentiment from Wall Street. As highlighted by Zacks Investment Research, Tenet Healthcare has an average brokerage recommendation of 1.39 on a scale of 1 to 5, which is between a "Strong Buy" and a "Buy". This consensus is based on ratings from 22 firms.

The positive analyst ratings are supported by the company's performance and future projections. Prior to a recent 1.22% dip, Tenet Healthcare shares had gained 19.40%, outperforming the Medical sector. Investors now anticipate its upcoming earnings, with projections for an Earnings Per Share (EPS) of $4.08 and net sales of $5.39 billion.

Year-to-date, Tenet Healthcare's shares have gained 2.60%, which contrasts with the industry's 5.50% decline. This growth is driven by expanding admissions and a strong Ambulatory Care segment. However, the company also faces a potential risk to its profit margins from rising operating expenses, which could impact future earnings.